LOX - lysyl oxidase Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100525278
LOX Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001206403.1 | NP_001193332.1 | protein-lysine 6-oxidase precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
protein-lysine 6-oxidase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13948 | Angiotensin II human | 99.98% | Unkown | |
| HY-13948A | Angiotensin II human acetate | 99.81% | Unkown | |
| HY-A0060 | Malotilate | Inhibitor | 99.47% | Unkown |
| HY-13948B | Angiotensin II human TFA | 98.29% | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-105028 | Tenidap | 99.93% | Phase 3 | |
| HY-106835 | Flobufen | Inhibitor | / | Phase 3 |
| HY-N0198 | Nordihydroguaiaretic acid | 99.93% | Phase 2 | |
| HY-117048 | PF-4191834 | Inhibitor | 99.48% | Phase 2 |
| HY-B1452 | Licofelone | 99.84% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99646 | Golocdacimab | Inhibitor | 99.11% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(170)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-Y1750 | β-Aminopropionitrile | Inhibitor | 99.99% | Unkown |
| HY-12341 | ML355 | Inhibitor | 98.11% | Unkown |
| HY-N0551 | Wedelolactone | 99.93% | Unkown | |
| HY-138153 | JKE-1674 | 99.97% | Unkown | |
| HY-111310 | ML351 | Inhibitor | 99.16% | Unkown |
| HY-23999 | BI-0115 | 99.72% | Unkown | |
| HY-113439 | 12-HETE | Inhibitor | 95.70% | Unkown |
| HY-138625 | PXS-5505 free base | Inhibitor | 99.97% | Unkown |
| HY-42484 | ER-076349 | Inhibitor | 99.72% | Unkown |
| HY-138625A | PXS-5505 anhydrous | Inhibitor | 99.90% | Unkown |
| HY-N0232 | Psoralidin | 99.90% | Unkown | |
| HY-N2176 | S-(+)-Marmesin | Inhibitor | 99.9% | Unkown |
| HY-108448 | N-Oleoyldopamine | 99.47% | Unkown | |
| HY-N0493 | Pectolinarigenin | 99.98% | Unkown | |
| HY-N1996 | Chebulagic acid | Inhibitor | 99.85% | Unkown |
| HY-N7108 | 7-Hydroxyflavone | 99.89% | Unkown | |
| HY-N2056 | 11-Keto-beta-boswellic acid | Inhibitor | 99.90% | Unkown |
| HY-13568 | Benoxaprofen | Inhibitor | 99.03% | Unkown |
| HY-138989 | 15-LOX-1 inhibitor 1 | Inhibitor | 98.81% | Unkown |
| HY-W020955 | Triphenylphosphinechlorogold | 99.93% | Unkown | |
| HY-113884B | (S)-Coriolic acid | Activator | 99.0% | Unkown |
| HY-N1881 | 4',5-Dihydroxyflavone | Inhibitor | 99.95% | Unkown |
| HY-170538 | SNT-5382 | Inhibitor | 99.96% | Unkown |
| HY-133159 | Resolvin E2 | 98.5% | Unkown | |
| HY-151499A | PXS-6302 hydrochloride | Inhibitor | 99.57% | Unkown |
| HY-10439 | HPGDS inhibitor 1 | Inhibitor | 99.42% | Unkown |
| HY-N10549 | Gigantol | 99.79% | Unkown | |
| HY-W010144 | Phenidone | Inhibitor | 98.96% | Unkown |
| HY-151498A | PXS-4787 hydrochloride | Inhibitor | 99.71% | Unkown |
| HY-171955 | LXG6403 | 99.85% | Unkown | |
| HY-W009248 | Phenethyl ferulate | Inhibitor | 99.66% | Unkown |
| HY-105024 | FPL 62064 | Inhibitor | 99.25% | Unkown |
| HY-124108 | Eicosatetraynoic acid | Inhibitor | 99.9% | Unkown |
| HY-N1942 | 5-O-Demethylnobiletin | Inhibitor | 99.91% | Unkown |
| HY-W041193 | 3-Hydroxy-2-pyrone | Inhibitor | 99.61% | Unkown |
| HY-113439S | 12-HETE-d8 | Inhibitor | 98.03% | Unkown |
| HY-128171 | Diflapolin | Inhibitor | 99.33% | Unkown |
| HY-139196 | ThioLox | Inhibitor | 99.74% | Unkown |
| HY-170573A | LOXL2-IN-1 tosylate | Inhibitor | 99.90% | Unkown |
| HY-N7012 | 7,3',4'-Tri-O-methylluteolin | 99.28% | Unkown | |
| HY-124674A | CCT365623 hydrochloride | 98.07% | Unkown | |
| HY-138939 | 5-LOX-IN-2 | Inhibitor | 98.12% | Unkown |
| HY-149922 | DKI5 | Inhibitor | 98.12% | Unkown |
| HY-169021 | JNK-1-IN-3 | Inhibitor | 98.44% | Unkown |
| HY-N3270 | Methyl orsellinate | Inhibitor | 99.91% | Unkown |
| HY-127170 | 3-Hydroxycoumarin | Inhibitor | 99.30% | Unkown |
| HY-W089800 | trans-2-Nonenal | 98.99% | Unkown | |
| HY-111140 | YS121 | 99.74% | Unkown | |
| HY-118480 | 4-MMPB | 98.54% | Unkown | |
| HY-121585 | CAY10698 | Inhibitor | 99.28% | Unkown |
| HY-Y1750A | β-Aminopropionitrile hydrochloride | Inhibitor | 99.76% | Unkown |
| HY-W028263 | 6-Hydroxyflavanone | Inhibitor | 99.87% | Unkown |
| HY-116124 | 17(S)-HpDHA | 99.48% | Unkown | |
| HY-116919 | MLS000536924 | Inhibitor | 98.20% | Unkown |
| HY-118110 | MLS000545091 | Inhibitor | 99.92% | Unkown |
| HY-125770 | 5(S)-HPETE | 98.0% | Unkown | |
| HY-125975 | 1-Naphthyl 3,5-dinitrobenzoate | Inhibitor | 99.49% | Unkown |
| HY-139055 | NCTT-956 | Inhibitor | 97% | Unkown |
| HY-148134 | 5-LOX-IN-1 | Inhibitor | 98.04% | Unkown |
| HY-151498 | PXS-4787 | Inhibitor | / | Unkown |
| HY-151499 | PXS-6302 | Inhibitor | / | Unkown |
| HY-158204 | CNB-001 | Inhibitor | / | Unkown |
| HY-N1965 | Gaultherin | Inhibitor | 99.44% | Unkown |
| HY-P2976 | Lipoxygenase, general | / | Unkown | |
| HY-W488004 | KKII5 | Inhibitor | 98.60% | Unkown |
| HY-155244 | 12R-LOX-IN-2 | Inhibitor | 99.85% | Unkown |
| HY-N9551 | Eriodictyol chalcone | Inhibitor | 97.25% | Unkown |
| HY-U00308 | 5-LOX-IN-4 | Inhibitor | 98.06% | Unkown |
| HY-W009671 | 3-Chloroiminodibenzyl | Inhibitor | 99.60% | Unkown |
| HY-138625B | PXS-5505 | Inhibitor | / | Unkown |
| HY-105504 | CI-986 | Inhibitor | / | Unkown |
| HY-111033 | RO5068760 | / | Unkown | |
| HY-114796 | tHGA | Inhibitor | / | Unkown |
| HY-114873 | LY256548 | Inhibitor | / | Unkown |
| HY-116763 | COX-2/5-LOX-IN-4 | Inhibitor | / | Unkown |
| HY-116866 | Sclerotiorin | Inhibitor | / | Unkown |
| HY-117317 | BLX-2477 | Inhibitor | / | Unkown |
| HY-117514 | 5-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-118506 | BRP-7 | Inhibitor | / | Unkown |
| HY-119462 | Tagorizine | Inhibitor | / | Unkown |
| HY-120502 | 5-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-124674 | CCT365623 | / | Unkown | |
| HY-124722 | OHM1 | Inhibitor | / | Unkown |
| HY-145473 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE | / | Unkown | |
| HY-146294 | COX-2/5-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-146295 | COX-2/5-LOX-IN-2 | / | Unkown | |
| HY-147870 | COX-2-IN-22 | Inhibitor | / | Unkown |
| HY-147951 | COX-2/5-LOX-IN-3 | Inhibitor | / | Unkown |
| HY-149269 | COX-2-IN-30 | Inhibitor | / | Unkown |
| HY-149270 | COX-2-IN-31 | Inhibitor | / | Unkown |
| HY-149476 | 5-LOX-IN-5 | Inhibitor | / | Unkown |
| HY-150548 | COX-2/15-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-150550 | COX-2-IN-26 | Inhibitor | / | Unkown |
| HY-150551 | COX-2-IN-27 | Inhibitor | / | Unkown |
| HY-150553 | COX-2-IN-28 | Inhibitor | / | Unkown |
| HY-151173 | XO/COX/LOX-IN-1 | Inhibitor | / | Unkown |
| HY-151426 | Anticancer agent 83 | Inducer | / | Unkown |
| HY-153279 | 5-LOX-IN-3 | Inhibitor | / | Unkown |
| HY-153930 | h15-LOX-2 inhibitor 1 | Inhibitor | / | Unkown |
| HY-155123 | Antioxidant agent-13 | Inhibitor | / | Unkown |
| HY-155159 | COX-2/15-LOX-IN-2 | Inhibitor | / | Unkown |
| HY-155160 | COX-2/15-LOX-IN-3 | Inhibitor | / | Unkown |
| HY-155161 | COX-2/15-LOX-IN-4 | Inhibitor | / | Unkown |
| HY-155243 | 12R-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-155409 | ALR-38 | Antagonist | / | Unkown |
| HY-155522 | WES-1 | Inhibitor | / | Unkown |
| HY-156329 | sEH/FLAP-IN-1 | Inhibitor | / | Unkown |
| HY-159169 | 5-LOX/sEH-IN-1 | Inhibitor | / | Unkown |
| HY-161315 | 15-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-162166 | COX-2/15-LOX/mPGES1-IN-1 | Inhibitor | / | Unkown |
| HY-162523 | hMAO-B-IN-8 | Inhibitor | / | Unkown |
| HY-162830 | 5-LOX/MAOs-IN-1 | Inhibitor | / | Unkown |
| HY-163187 | COX-2/LOX-IN-1 | Inhibitor | / | Unkown |
| HY-163188 | COX-2/LOX-IN-2 | Inhibitor | / | Unkown |
| HY-163355 | COX-2/15-LOX-IN-5 | Inhibitor | / | Unkown |
| HY-163736 | mPGES-1/5-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-168340 | COX-2/15-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-168632 | Topoisomerase I/II inhibitor 6 | / | Unkown | |
| HY-170573 | LOXL2-IN-1 | Inhibitor | / | Unkown |
| HY-170938 | AChE-IN-82 | Inhibitor | / | Unkown |
| HY-170957 | 5-LOX/NO-IN-1 | Inhibitor | / | Unkown |
| HY-172790 | Cbz-(S,S)-Pro-Pro-allyl | Inhibitor | / | Unkown |
| HY-172877 | EGFR/BRAFV600E-IN-5 | / | Unkown | |
| HY-173056 | Ruthenoleuton | Inhibitor | / | Unkown |
| HY-173115 | 15-LOX-IN-2 | / | Unkown | |
| HY-173180 | 5-LOX-IN-8 | Inhibitor | / | Unkown |
| HY-173332 | 15-LOX-1 inhibitor 2 | Inhibitor | / | Unkown |
| HY-175034 | Topoisomerase I/II-IN-1 | / | Unkown | |
| HY-175245 | hCA-IN-1 | Inhibitor | / | Unkown |
| HY-175970 | MLS000099089 | Inhibitor | / | Unkown |
| HY-179021 | COX-2/15-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-179441 | sEH/FLAP-IN-2 | Inhibitor | / | Unkown |
| HY-180363 | E 6080 | Inhibitor | / | Unkown |
| HY-180581 | LOXL2/sGC modulator-1 | / | Unkown | |
| HY-181044 | COX-2/5-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-181061 | COX/5-LO-IN-2 | / | Unkown | |
| HY-181273 | COX-2/5-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-183764 | COX-2/5-LOX-IN-8 | Inhibitor | / | Unkown |
| HY-B1452S1 | Licofelone-d6 | / | Unkown | |
| HY-N16694 | 6,7-Dehydroferruginol | Control | / | Unkown |
| HY-N17462 | Methyl 9-hydroxyoctadeca-10,12,15-trienoate | Inhibitor | / | Unkown |
| HY-N18218 | Speranskoside | Inhibitor | / | Unkown |
| HY-N18235 | (1Z)-Atractylodinol | Inhibitor | / | Unkown |
| HY-N19723 | Buddlejasaponin I | Inhibitor | / | Unkown |
| HY-N19724 | Buddledin A | Inhibitor | / | Unkown |
| HY-N2266 | Benzoylgomisin O | Inhibitor | / | Unkown |
| HY-N8480 | Atractylochromene | Inhibitor | / | Unkown |
| HY-N8764 | Decaffeoylacteoside | Inhibitor | / | Unkown |
| HY-P10458 | 5-Lipoxygenase blocking peptide | Inhibitor | / | Unkown |
| HY-RS07739 | LOX Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W009640 | Mofebutazone | Inhibitor | 98.42% | Unkown |
| HY-W009640A | Mofebutazone sodium | Inhibitor | / | Unkown |
| HY-W676872 | Dihydroflavokawin B | Inhibitor | / | Unkown |
| HY-W778179 | Benoxaprofen-13C,d3 | Inhibitor | / | Unkown |
| HY-113807 | ZLJ-6 | Inhibitor | / | Unkown |
| HY-118268 | RG 6866 | Inhibitor | / | Unkown |
| HY-118848 | A63162 | Inhibitor | / | Unkown |
| HY-133215 | Zileuton sulfoxide | Inhibitor | / | Unkown |
| HY-155407 | ALR-6 | Antagonist | / | Unkown |
| HY-155408 | ALR-27 | Antagonist | / | Unkown |
| HY-161907 | h15-LOX-2 inhibitor 2 | Inhibitor | / | Unkown |
| HY-161908 | h15-LOX-2 inhibitor 3 | Inhibitor | / | Unkown |
| HY-168768 | FerroLOXIN-1 | Inhibitor | / | Unkown |
| HY-N0493R | Pectolinarigenin (Standard) | / | Unkown | |
| HY-N11072 | Tremulacin | Inhibitor | 96.41% | Unkown |
| HY-N15453 | Asperenone | Inhibitor | / | Unkown |
| HY-N2056R | 11-Keto-beta-boswellic acid (Standard) | Inhibitor | / | Unkown |
| HY-RS16507 | Lox Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22939 | Lox Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-Y1750R | β-Aminopropionitrile (Standard) | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service